Announcement of License Agreement with BioSpring GmbH for the Manufacture of Oligonucleotides Using XNA Technology 2025/10/09 Notice Read
Our President and CEO, Mr. Hideaki Sato will give a presentation at RNA World 2025 2025/08/29 Event Read
Luxna Biotech selected as first-phase supported startup in Nakanoshima Qross Cluster Program 2025/08/19 Event Read
Poster Presentations at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan 2025/06/13 Event Read
